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Abstract 
The Effects of E-Cigarette Exposure on the Peripheral Vasculature 
Christopher Pitzer 
E-cigarettes have emerged as popular alternatives to traditional smoking, partially because of 
efforts of manufacturers to portray them as safe. Recent studies have cast doubt on claims of 
safety, our lab has published data showing a significant impairment in endothelium-dependent 
dilation with chronic exposure, however the acute temporal effects and mechanisms involved 
with E-cigarette exposure on the vasculature are still poorly characterized. This study uses an 
intravital microscopy approach to evaluate the effects of acute time course changes following 
E-cigarette vapor exposure on second-order arterioles in the gluteus maximus muscle of mice. 
We hypothesized that endothelial impairment would be observed with a single E-cigarette 
exposure. C57BL/6 mice were anesthetized and a portion of the gluteus maximus muscle was 
externalized to allow visualization of second order arterioles. Arteriolar tone was monitored for 
up to 120-minutes in one study to determine the effects of E-cigarette exposure. In a separate 
study, vascular function was assessed by dilation to acetylcholine 50 minutes after exposure to 
a single 5-minute (10 puff) exposure to E-cigarette vapor. Significant vasoconstriction occurred 
in E-cigarette exposed animals with or without nicotine using 50:50 vegetable 
glycerin/propylene glycol (VG/PG-18 and VG/PG-0, respectively, p<0.05), as well as in animals 
exposed to 100% PG with no nicotine (PG-0) and 100% VG with no nicotine (VG-0). E-cigarette 
responses were similar to animals exposed to traditional tobacco-based 3R4F reference 
cigarette (3R4F). No significant differences in vessel response to acetylcholine pre- vs. post-
exposure were generally found; except with VG/PG-18, which showed significant increase in 
acetylcholine curve slope after vaping. Assessment of growth factor and cytokines response 
following chronic (8-month) exposure to E-cigarette exposure was obtained from a separate 
study which we have previously show impaired vascular function (Olfert et al. 2018). Cytokine 
quantification was performed using a multiplex kit from Meso-Scale Discovery (Rockville, MD, 
US) on homogenates of lung, gastrocnemius muscle, serum and bronchoalveolar lavage fluid 
(BALF) in C57BL/6 mice exposed to filtered room air (AIR), 3R4F cigarette, and Cappuccino-
flavored E-cigarette vapor (E-CIG, 50:50 VG/PG). IL-6 in the serum of E-CIG animals was 
significantly lower than AIR animals (P<0.05). VEGF tended to be lower in BALF and lungs of E-
CIG animals relative to air controls. Granulocyte-macrophage colony stimulating factor (GM-
CSF) also tended to be lower in E-CIG animals relative to 3R4F and AIR animals. Collectively, our 
data shows that acute E-cigarette exposure causes peripheral constriction (~20%) of blood 
vessels independent of nicotine and suggests that the base components of E-liquid cause 
vasoconstriction to a similar degree. Endothelial dilatory capacity is largely unaffected by E-
cigarette exposure after 1-hour following a single acute exposure. Chronic E-cigarette exposure 
alters the expression of IL-6 in the serum and may affect expression of VEGF in the lungs and 
BALF and GM-CSF expression in the lungs. Taken together these data suggest that vaping has 
acute effects on the basal blood vessel tone that is similar to traditional cigarettes, suggesting 
the chronic E-cigarette use is likely to produce long-term vascular health consequences similar 
to that observed with cigarette smoking.
iii 
 
 
Table of Contents 
Chapter 1: Background and Significance ..................................................................................................... 1 
1.1 Overview of E-cigarette Function and Potential Toxicities ................................................................. 2 
1.2 Comparison of toxicity of E-cigarettes and Traditional Cigarettes ..................................................... 4 
1.3 Effects of E-cigarettes on Immune System Function and Cytokine Expression. ................................. 9 
1.4 E-cigarette and Tobacco Use and Regulations. ................................................................................. 12 
1.5 Effects of E-cigarettes and Traditional Cigarettes on Vascular Reactivity. ....................................... 13 
1.6 Overview and History of Intravital Microscopy to Study the Vasculature and Effects of Smoking. . 17 
1.7 Factors Influencing Peripheral Vascular Tone and Potential Effects of E-cigarettes ........................ 19 
 1.7.1 Effects on the Endothelium .................................................................................................. 20 
 1.7.2 Effects of the Arachidonic Acid Pathway  ............................................................................. 20 
 1.7.3 Effects of Thrombospondin-1 and its Receptor CD47 .......................................................... 21 
 1.7.4 Effects of Endothelin-1 .......................................................................................................... 22 
 1.7.5 Effects of the Renin/Angiotensin System  ............................................................................ 23 
 1.7.6 Potential Sympathomimetic Effects of Vapor Constituents  ................................................ 24 
Chapter 2: Specific Aims ............................................................................................................................. 25 
Chapter 3: Methods ................................................................................................................................... 29 
3.1 Intravital Surgery Prep  ............................................................................................................ 30 
3.1.1 Intravital Study 1 ...................................................................................................... 33 
3.1.2 Intravital Study 2 ...................................................................................................... 34 
3.2 Cytokine Analysis Experiments ................................................................................................ 35 
Chapter 4: Results ...................................................................................................................................... 38 
Study 1: 2-Hour Time Course ......................................................................................................... 39 
Study 2: Vascular Reactivity after 50-Minutes following Vaping  .................................................. 44 
Study 3: Chronic Exposure and cytokine analysis .......................................................................... 49 
Chapter 5: Discussion, Limitations and Future Directions ........................................................................ 52 
Discussion ...................................................................................................................................... 53 
Acute Time Course Responses .......................................................................................... 53 
Vascular Reactivity  ........................................................................................................... 56 
Cytokine Analysis .............................................................................................................. 59 
iv 
 
Limitations ..................................................................................................................................... 60 
Future Work ................................................................................................................................... 62 
Works Cited .................................................................................................................................... 65 
 
 
 
 
 
1 
 
 
 
 
 
 
 
 
 
 
Chapter 1: Background and Significance 
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1.1 Overview of E-cigarette Function and Potential Toxicities 
 Since they first appeared on the US market in 2006, E-cigarettes have evolved from 
disposable  “cig-a-like” devices to refillable  “tank style” devices (U.S. Food & Drug 
Administration, 2016) (Figure 2.1).  The evolution of E-cigarette products now includes larger 
“mods” devices with variable temperature, resistance and voltage settings. E-cigars and E-pipes 
have recently appeared in US markets but despite different appearances, function in the same 
manner as other E-cigarettes. 
Despite the differences in appearance all E-cigarettes operate by heating a “base” 
mixture of propylene glycol and vegetable glycerin, that also contains flavoring and in most 
cases nicotine, to the point of evaporation allowing the user to inhale the aerosol (Ikonomidis 
et al., 2018). Different refill liquids for E-cigarettes are known to contain flavorings that upon 
heating can generate potentially toxic compounds, many of which are cytotoxic to endothelial 
cells(e.g. cinnamaldehyde) (Behar et al., 2014; P. W. Clapp & Jaspers, 2017). Many devices offer 
variable voltage or temperature settings which may change the composition of the aerosol with 
higher voltages generally resulting in higher concentrations of breakdown products (Kosmider 
et al., 2014).  
It is believed that the breakdown of the base solvents during heating leads to the 
generation of carbonyl compounds that are known to be carcinogenic (Cassee et al., 2008; 
Tyihák, Bocsi, Timár, Rácz, & Szende, 2001) It is also possible that with repeated heating, 
particles of metal from the atomizer become aerosolized and inhaled (Hess et al., 2017; Nayir, 
Karacabey, Kirca, & Ozdogan, 2016). E-cigarette liquids themselves have also been shown to  
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Figure 1.1: Image from CDC Surgeon General Report (Center for Disease Control and 
Prevention, 2011) depicting various E-cigarette devices of different generations. 
 
contain nitrosamines, compounds that are inflammatory and carcinogenic (Farsalinos, Gillman, 
Poulas, & Voudris, 2015; H. J. Kim & Shin, 2013). Studies using cell culture techniques have 
shown that exposure to E-cigarette aerosol extract can suppress antioxidant defenses and 
increase oxidative DNA damage (Ganapathy et al., 2017). The decrease in antioxidant capacity 
and induction of DNA damage may be a potential mechanism for tumorigenesis.  
E-cigarette liquid has also been shown to increase the rate of viral infection of cells that 
have been exposed to it (Wu, Jiang, Minor, & Chu, 2014). Decreased immunity in the airways 
may lead to increased infection rates in the upper respiratory tract. This process is likely 
mediated through altered function of neutrophils, which have been shown to be activated in 
the lungs in response to E-cigarette vapor exposure (Hwang et al., 2016) as well as increased 
secretion of proinflammatory cytokines (Higham et al., 2016).   
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 An emerging body of evidence has shown that E-cigarette liquids are cytotoxic to 
human vascular endothelial cells (Anderson, Majeste, Hanus, & Wang, 2016; Putzhammer et al., 
2016). This toxicity is a likely mechanism of decreased endothelium dependent dilation seen 
with E-cigarette exposure studies (Carnevale et al., 2016; Olfert et al., 2018). It is also likely that 
endothelial cell toxicity can lead to the development of atherosclerosis by increasing 
endothelial permeability. One recent study shows that exposing human vascular endothelial 
cells to E-cigarette aerosol extract results in both apoptosis and programmed necrosis 
pathways leading to increases in DNA fragmentation (Anderson et al., 2016).  These changes 
were resolved upon treatment of cells with antioxidants (Anderson et al., 2016), suggesting that 
oxidative damage to endothelial cells is likely to lead to vascular impairment and an increased 
risk for CVD (Qasim, Karim, Rivera, Khasawneh, & Alshbool, 2017). 
 
1.2 Comparison of toxicity of E-cigarettes and traditional cigarettes 
 Determining the relative toxicity of E-cigarettes compared to traditional cigarettes has 
been a recent focus in the literature. Effects of E-cigarettes and traditional cigarettes on air 
quality is emerging as a public health concern. It is well documented that the vapor produced 
by E-cigarettes is less complex than smoke from combustible cigarettes (Carnevale et al., 2016; 
P. W. Clapp & Jaspers, 2017). Decreased complexity does not simply equate to decreased 
toxicity however, as some compounds linked to E-cigarette vapor have been shown to be 
cytotoxic (Behar et al., 2014; Farsalinos, Gillman, et al., 2015). Other studies using ultra-high 
performance liquid chromatography tandem mass spectrometry (UHPLC-MS) methods have 
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found concentrations of chemicals known to be corrosive or toxic in vapor extracts, these 
chemicals were not present in the liquid before vaporizing (Higham et al., 2016). Recent data 
has also shown that E-cigarette vapor exposure is linked to development of a COPD phenotype 
in mice in a nicotine dependent manner (Garcia-Arcos et al., 2016). This is likely due to the 
interactions of constituents of E-cig vapor with neutrophils present in the lungs (Higham et al., 
2016). 
 The presence of formaldehyde and acetaldehyde has been demonstrated in both the 
smoke of traditional cigarettes and in E-cigarette vapor (Kosmider et al., 2014; Ogunwale et al., 
2017; Wang et al., 2009). The relative quantities of toxic aldehydes in each remains 
controversial. While studies of early generation E-cigarette products showed greatly decreased 
aldehyde concentrations (Ogunwale et al., 2017), studies of newer variable temperature and 
voltage devices show that levels of aldehydes approach those of traditional cigarettes 
(Ogunwale et al., 2017). An argument proposed by Jensen et al. claims that a large portion of 
aldehydes present in E-cigarette vapor are “hidden” as aldehyde containing hemiacetals, which 
are broken down to formaldehyde in the body but undetected by traditional aldehyde 
detecting methods (Seifter, 2014). Experimental confirmation of this hypothesis is warranted, 
as aldehydes are highly toxic and high levels found in E-cigarette vapor would be a public health 
concern. 
 Proteomic analysis has shown that there are biological effects of aldehydes in the lungs 
of E-cigarette users. Reidel et al. have shown that E-cigarette exposure significantly increases 
expression of aldehyde detoxifying enzymes, oxidative stress response proteins, and matrix 
metalloproteinase-9 (MMP-9) in the sputum of E-cigarette users (Reidel et al., 2017; Reidel et 
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al., 2010). The levels of these enzymes were comparable to those found in cigarette smokers, 
possibly indicating a nonlinear toxicity of reactive carbonyls in the lungs (if levels of the 
aldehydes are indeed lower in E-cigarettes). The other elevated proteins found in the 
secretomes of subjects in these studies are also important, oxidative stress as well as increased 
levels of MMP-9 are known to exacerbate development of the COPD phenotype (Mercer et al., 
2005). 
 From a vascular perspective, the amount of oxidative stress E-cigarettes cause is 
somewhat controversial. Ikonomidis et al. have shown that arterial stiffness and markers of 
oxidative stress are decreased with use of E-cigarettes when compared to traditional cigarettes 
(Ikonomidis et al., 2018). Other studies have however shown that particulate matter of similar 
size to that found in E-cigarettes can cause rapid and lasting cardiovascular toxicity via oxidative 
mechanisms (Brook et al., 2002; Kampfrath et al., 2011).  
Analysis of particulate matter emitted from E-cigarettes has shown that the number of 
particles inhaled from a puff of an E-cigarette are approximately equal to, if not slightly greater 
than those of a traditional cigarette (Ingebrethsen, Cole, & Alderman, 2012; Thorne et al., 
2016). There is less consensus in determining the mutagenic potential of those particles. 
Thorne et al. have shown that E-cigarette aerosol is not mutagenic to two different strains of 
Salmonella typhimurium (Thorne et al., 2016). This contradicts the findings of Ganapathy, who 
found a potential mechanism of mutagenesis via suppression of antioxidant defenses and 
induction of oxidative DNA damage to cultured human mouth and lung epithelial cells 
(Ganapathy et al., 2017). These results, while interesting, may not be appropriate for 
determining mutagenic capacity, as Ganapathy et al. (while using human cells) did not attempt 
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to match for an average exposure of those cells in realistic use.  The concentrations these cells 
were exposed to may have been higher doses than mouth or lung epithelium would realistically 
be exposed to even with regular use. The overall mutagenic capacity of E-cigarettes in real use 
situations is still unclear, and thus real comparisons to traditional cigarettes is still poorly 
understood.  
Studies comparing the effects of E-cigarette and traditional cigarette on indoor air 
quality have also yielded conflicting results. McAuley et al. found no immediate risk to human 
health from E-cigarette emissions in their study which used a 40-cubic meter room as an 
exposure chamber while testing for compounds traditionally found in secondhand smoke 
(McAuley, Hopke, Zhao, & Babaian, 2012). In a study with a 45-cubic meter exposure chamber, 
Schober et al. found significantly elevated levels of 1,2-propanediol, nicotine, glycerin and 
aluminum. 1,2-propanediol is of particular concern in this study as particles from secondhand 
exposure may deposit in the lungs, where irritation may occur (Schober et al., 2014). Another 
study, which took air samples before and during an E-cigarette convention (room volume 4023 
cubic meters) found 125-330 times higher levels of particulate matter smaller than 2.5 
micrometers during the event (Soule et al., 2018). Inhalation of particulate matter of this size 
distribution has been linked to acute cardiovascular dysfunction (Brook et al., 2002). Overall, 
the effects of secondhand E-cigarette exposure poorly characterized and more research is 
warranted to determine safety and inform policy decisions. 
Because of marketing campaigns suggesting that E-cigarettes are safe, or safer, relative 
to combustible cigarettes, and recommendations of other governments to reduce harm by 
replacing cigarettes with E-cigarettes, the use of E-cigarettes as a smoking cessation aid has 
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been suggested (Brown, Beard, Kotz, Michie, & West, 2014; Christopher Bullen et al., 2013; 
Orellana-Barrios, Payne, Medrano-Juarez, Yang, & Nugent, 2016). E-cigarettes are not, however 
approved as cessation aids in the United States by the FDA, due largerly to a lack of literature 
definitively illustrating E-cigarettes as safer alternatives and the publication of studies showing 
that E-cigarettes are likely minimally effective in promoting cessation (Brown et al., 2014; 
Caponnetto et al., 2013; Orellana-Barrios et al., 2016). Bullen et al. have shown that 
participants reported a significant decrease in satisfaction using E-cigarettes compared to 
traditional cigarettes (C. Bullen et al., 2010). This is an important result, as behavioral analysis 
of individuals who smoke, even those who desire to quit, report satisfaction with the act of 
handling and lighting traditional cigarettes (Jarvis, 2004). The absence of the rituals (handling 
boxes, lighting the cigarette, etc.) that cigarette smokers have become attached to may 
decrease the efficacy of E-cigarettes as smoking cessation tools. 
Overall, the comparison of traditional combustible cigarettes to E-cigarettes is not likely 
an “apples to apples” comparison. The variability of E-cigarette device settings as well as the 
number of brands, flavorings and base liquid mixtures presents a degree of difficulty in 
comparing E-cigarettes to traditional cigarettes. Studying the biological effects of E-cigarettes is 
also difficult since the effects of each variable component of E-cigarettes on vapor content and 
biological activity is poorly understood. E-cigarettes are also not recommended as 
replacements for traditional cigarettes because there is a lack of evidence that they are 
effective cessation tools, some studies even report a “dual use” effect where users maintain 
daily cigarette intake and use E-cigarettes also (Correa et al., 2018; Orellana-Barrios et al., 
2016). 
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1.3 Effects of E-cigarettes on Immune System Function and Cytokine Expression. 
 The relative newness of E-cigarettes (<12 years) makes the study of long-term effects on 
humans difficult, in part, because smoking-related heart disease and COPD is often found only 
after several decades of exposure. This has made animal models and cell culture experiments 
increasingly important to gain early insight in determining potential risks with chronic E-
Cigarette before decades must pass for us to understand the consequences vaping of humans. 
Because the lungs are the primary site of contact, studies of pulmonary immunity have been a 
recent priority of the literature (Hwang et al., 2016; Sussan et al., 2015; Wu et al., 2014). Cell 
culture studies are also valuable for this process also as they allow for precise control of 
exposure dose and monitoring of the response of individual cell populations.  
 Pulmonary injury is a major concern of current E-cigarette research. Recent data has 
linked E-cigarette exposure to an increase in Th2 cytokines (Interleukins 4,5,10 and 13 (Barnes, 
2001)) in the lungs.  Th2 cytokines are thought to be responsible for sensitization of the lungs 
and a potential cause of asthma (P. W. Clapp & Jaspers, 2017). Development of asthma is of 
particular concern among younger users, the US Surgeon General reports that use of E-
cigarettes among middle school students is approximately equal to use among adults over 25 
(US Department of Health and Human Services, 2017). E-cigarette exposure in mice has also 
been shown to induce a COPD phenotype in a nicotine-dependent manner (Garcia-Arcos et al., 
2016). The progression of COPD has been shown to worsen through increases in pro-
inflammatory cytokines, mostly coming from neutrophils (neutrophil associated cytokines 
include IL-8, leukotriene B4 and tumor-necrosis-factor-alpha, TNF-α) (Reid & Sallenave, 2003). 
E-cigarette use has also been shown to increase presence of neutrophils in the lung (Boris 
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Reidel, Giorgia Radicioni, Phillip Clapp, Amina A Ford, Sabri Abdelwahab, Meghan E Rebuli, 
Prashamsha Haridass, Neil E Alexis & Kesimer, 2010; Hwang et al., 2016) and increase the 
inflammatory response of the neutrophils (Higham et al., 2016) pointing to a possible concern 
of COPD development in chronic users.  
Altered immune cell expression in the lungs also results in altered immune system 
efficiency. Exposure to E-cigarette exposure in mice has been shown to increase presence of 
bacterial colonies (Hwang et al., 2016). This is likely due, at least in part, to a decrease in 
phagocytosis of macrophages caused by E-cigarette exposure (Sussan et al., 2015). Studies have 
also shown increased rates, duration and severity of viral infection upon exposure to E-cigarette 
vapor (Sussan et al., 2015; Wu et al., 2014).  Increased infection and duration may also play a 
role in the pathogenesis of the COPD phenotype, increasing neutrophil presence in the lung 
(and as described above has been linked to decreased activity of NK cells (PRIETO et al., 2001) 
as well as decreased phagocytic activity (Drannik et al., 2004)). This dysfunction in the immune 
system may lead to exacerbations of COPD, leading to reductions in lung function which is an 
important cause of death of patients with COPD (Hoenderdos & Condliffe, 2013). 
While there is little data available in the context of E-cigarettes’ effect on cytokine 
expression, the effects of cigarettes are well characterized. Likely the first proinflammatory 
mechanism to be activated upon inhalation of cigarette smoke is the NF-κB pathway. NF-κB has 
been shown to increase the release of IL-8 as well as TNF-α (Yang et al., 2006). While the direct 
effects of E-cigarettes on NF-κB have yet to be directly studied, chemicals commonly used to 
flavor E-cigarettes have been shown to significantly increase IL-8 production in cultured 
monocytic cell lines (Muthumalage et al., 2018). This finding is interesting because the isolated 
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flavoring chemicals were used rather than whole base liquids, meaning the increases in IL-8 
happen independently of nicotine concentration. NF-κB has also been shown to modify histone 
de-acetylases after transcription (Yang et al., 2006), this is likely to increase the period of time 
that proinflammatory genes remain upregulated after exposure to inflammatory stimuli. While 
it is likely that E-cigarette flavorings increase IL-8 secretion through an NF-κB dependent 
mechanism this has yet to have been experimentally confirmed, further study is necessary to 
determine the effects of E-cigarettes on NF-κB and the cytokines that it promotes. 
 One of the most potent inflammatory mediators in acute cigarette exposure is TNF-α. 
Churg et al. have shown that TNF- α is necessary for the alteration of gene expression and onset 
of tissue breakdown associated with acute cigarette exposure (Churg, Dai, Tai, Xie, & Wright, 
2002). TNF- α has also been shown to increase levels of membrane metalloproteinase enzymes, 
which are known to cause vascular remodeling and affect wound healing (Han, Tuan, Wu, 
Hughes, & Garner, 2001). Caspase enzymes, which have been shown to increase levels of 
endothelial apoptosis, also have been shown to increase with elevated levels of TNF- α (Csiszar, 
Ungvari, Koller, Edwards, & Kaley, 2004). It is important to note that endothelial cell apoptosis 
is likely to increase systemic circulation of IL-8 which is a potent neutrophil chemotactic factor, 
and since neutrophils can secrete TNF- α a positive feedback loop consisting of neutrophilia, 
TNF- α secretion, caspase activation and IL-8 secretion is not difficult to imagine regarding 
cigarette and E-cigarette exposure. 
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Figure 1.2 shows a potential mechanism of positive feedback following E-cigarette exposure. In 
this mechanism E-cigarette exposure drives neutrophil infiltration of the lungs and stimulates 
secretion of TNF-α, which through a caspase enzyme mediated mechanism drives endothelial 
cell apoptosis and causes increased secretion of IL-8. IL-8 drives further neutrophilia of the lung 
by its action as a chemotactic factor. 
 
1.4 E-cigarette and tobacco use and regulations 
 In 2016 the FDA expanded its definition of “tobacco products” to include E-cigarettes, 
liquids, and atomizers (U.S. Food & Drug Administration, 2016).  Emerging concerns about the 
quality and manufacturing of E-cigarettes and E-liquids has led to manufacturing regulations of 
E-cigarette products effective beginning August 2018, as well as age restrictions to purchasing 
E-cigarette products (U.S. Food & Drug Administration, 2016).  
 Marketing campaigns by E-cig manufacturers portray their devices as “safe alternatives” 
to traditional cigarettes, but the good news is that a majority (72%) of Americans recently 
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surveyed believe that E-cigarettes will harm the health of users (“American S ’ Perspectives on 
E-Cigarettes,” 2015). When considering the public opinions surrounding E-cigarettes, it is not 
surprising that 5 US states and over 400 counties have laws prohibiting the use of E-cigarettes 
indoors and other places where traditional smoking is prohibited (“American S ’ Perspectives on 
E-Cigarettes,” 2015). Other public health concerns surrounding E-cigarettes are also present; for 
example studies have shown that inaccurate nicotine content has been found with E-liquid 
manufacturing (Buettner-Schmidt, Miller, & Balasubramanian, 2016; Castranova, Asgharian, 
Sayre, Virginia, & Carolina, 2016). Childproof containers are also infrequently used to contain E-
liquid, this is of concern because fatal amounts of nicotine may be absorbed through the mouth 
or skin of a child (Buettner-Schmidt et al., 2016). One such death in the United states, in 2014, 
has prompted several states to adopt legislation requiring manufacturers to use childproof 
containers package their products (Frey & Tilburg, 2016). 
 
1.5 Effects of E-cigarettes and traditional cigarettes on vascular reactivity 
 Cigarette smoke has long been associated with vascular dysfunction (Lehr, 2000), the 
superoxide anion produced while smoking is thought to play a role in decreasing nitric oxide 
(NO) availability and damaging the endothelial cells that produce NO (Raij, DeMaster, & Jaimes, 
2001). One of the most common means of testing endothelial function is testing reactivity to 
acetylcholine. Acetylcholine interacts with soluble guanylyl cyclase to increase concentration of 
cyclic guanylyl monophosphate (cGMP); increases in cGMP causes stimulation of endothelial 
nitric oxide synthase (eNOS) and through a calcium dependent mechanism causes release of 
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endothelium derived relaxing factors (EDRF)  that cause relaxation of vascular smooth muscle 
cells(Thomsen, Rubin, & Lauritzen, 2000).  
 Reactivity of blood vessels to acetylcholine is often used as a measure of vascular health 
(Figure 2.3).  Lekakis et al. have shown that acute cigarette smoke exposure alters endothelial 
function in humans (Lekakis et al., 1997). While it is known that conditions such as hypoxia and 
inflammation may decrease the ability of the endothelium to produce NO (B. R. Clapp et al., 
2004; Jeremy, Yim, Wan, & Angelini, 2002), there are few studies detailing the effects of acute 
E-cigarette exposure on endothelial function. It is however known that pulmonary exposure to 
cigarette smoke increases activity of nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase (an enzyme responsible for the generation of free radicals) (M. Kim, Han, & Lee, 2014).  
NADPH oxidase is responsible for the generation of the superoxide ion, a free radical 
that has been shown to preferentially react with nitric oxide to form peroxynitrite (Beckman & 
Koppenol, 1996). Excess peroxynitrite in the vasculature is associated with a decrease in 
dimerization of eNOS and a shift towards the production peroxynitrite by the eNOS enzyme 
itself in a process called eNOS uncoupling (Förstermann & Münzel, 2006). eNOS uncoupling is 
likely caused by the oxidation of tetrahydrobiopterin (BH4), a cofactor of eNOS that causes 
dimerization. BH4 is oxidized by peroxynitrite quickly in the endothelial cells (Kuzkaya, 
Weissmann, Harrison, & Dikalov, 2003). Asano et al. have shown that NADPH oxidase activity 
(and presumably endothelial uncoupling) is significantly elevated upon exposure to nicotine and 
tar free cigarette smoke extract (Asano et al., 2012). While nicotine is not required for NADPH 
oxidase activity to be upregulated there is also an experimentally determined role of nicotine in 
this pathway; fang et al. have shown that inhibition of NADPH oxidase improves vascular 
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reactivity with chronic intraperitoneal injections of nicotine (Fang, 2006). These results are 
important when considering the potential impact of E-cigarettes on vascular reactivity, while 
nicotine may play a role in exacerbating NADPH oxidase activity, particulate matter emitted 
from E-cigarettes is also likely to play a role in NADPH oxidase upregulation and therefore 
vascular dysfunction (Kampfrath et al., 2011). This implies that E-cigarettes containing zero 
nicotine are also likely to decrease vascular reactivity. 
Shown in Figure 2.3, calcium-dependent and -independent mechanisms of NO synthesis 
by the endothelium. The effects on this pathway as described above relate only to the calcium 
dependent mechanisms. The rightmost depiction in the figure illustrates the mechanism of 
vascular smooth muscle constriction to acetylcholine when the endothelium is damaged. 
 Figure 1.3 shows the calcium dependent pathway of NO synthesis (the pathway through 
which acetylcholine acts), the calcium independent pathway of NO synthesis and the 
mechanism by which acetylcholine can cause vasoconstriction when vascular endothelium is 
damaged. 
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The calcium-independent pathway of NO synthesis involves the distension of the 
glycocalyx that lines the luminal surface of endothelial cells. As shown in Figure 2.3 the 
distension of glycocalyx branches causes activation of eNOS independently of calmodulin in the 
endothelium. Blood viscosity is important in the generation of NO in this manner and cigarette 
smoking has been shown to increase blood viscosity and decrease the ability of blood to exert 
sufficient shear stress on the glycocalyx to stimulate eNOS(Original Article, 2011). The effects of 
cigarette smoking on blood viscosity are likely due to increases in fibrinogen (Haustein, Krause, 
Haustein, Rasmussen, & Cort, 2002). The effects of E-cigarettes on blood viscosity have yet to 
be studied, further research is needed to determine if E-cigarette exposure will affect eNOS 
activity in this way.  
Apoptosis of endothelial cells is another potential mechanism of dysfunction, especially 
in the context of chronic use of cigarettes and E-cigarettes; endothelial cells can undergo a 
specific type of apoptosis called anoikis, in which the cells detach from the extracellular matrix 
and enter circulation (Boos, Balakrishnan, Blann, & Lip, 2008). Raveendran et al. showed that 
priming endothelial cells to secrete NO had a protective effect on the cells upon exposure to 
cigarette smoke (Raveendran et al., 2005). This means that oxidative damage to endothelial 
cells by cigarettes or E-cigarettes may be prevented at the expense of NO bioavailability in vivo. 
Further oxidative stress on the endothelium may occur as the neutrophil response to E-
cigarettes occurs, proinflammatory cytokines secreted by neutrophils may also effect NO 
bioavailability (B. R. Clapp et al., 2004) and endothelial cell apoptosis. 
 Vasomotor impairment caused by endothelial dysfunction is a precursor to CVD, 
cigarette smoke has been shown to cause endothelial dysfunction and vasomotor impairment 
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(Celermajer et al., 1993; Raij et al., 2001; Rubenstein, Yong, Rennard, & Mayhan, 1991; With & 
Artery, 2018). The effects of E-cigarette exposure on the endothelium is not as well 
characterized, however a recent study from our laboratory has found chronic exposure to vapor 
has been shown to decrease endothelial dependent dilation in the aorta of mice (Olfert et al., 
2018). This is important to consider when evaluating the safety of E-cigarettes as it implies a 
state of increased oxidative stress on the vasculature, which is known to decrease endothelial 
function, and lead to disease states such as atherosclerosis, coronary artery disease and heart 
failure (Anderson et al., 2016; B. R. Clapp et al., 2004; Kitta et al., 2009). The acute and chronic 
effects of E-cigarettes on vascular structure and function need further study, particularly 
toward the risk endothelial cells pose for development of CVD with chronic use. 
 
1.6 Overview and History of Intravital Microscopy to Study the Vasculature and Effects of 
Smoking 
 Intravital microscopy is a procedure in which a living system is visualized while the 
organism being studied is still alive. These techniques have long been used to characterize the 
effects of toxicants on the vasculature and on the circulating immune cells. The body of 
literature concerning traditional cigarettes and isolated nicotine from an intravital perspective 
is quite robust (Álvarez et al., 2004; Kubes, Suzuki, & Granger, 1991; Lehr, 2000; Lehr, Frei, & 
Arfors, 1994; W G Mayhan & Sharpe, 1998; William G. Mayhan, 1999; Rubenstein et al., 1991), 
there is however minimal data concerning E-cigarettes in this capacity. 
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 By the 1960’s scientists established a link between smoking and heart disease (William, 
Thomas, Sandra, Doyle, & Dawber, 1964).  To address this issue and elucidate mechanisms, 
intravital studies became a popular means of visualizing the vasculature, and the cells it 
contains. Through these studies, investigators found a decrease in endothelium dependent 
dilation (Ambrose & Barua, 2004; Anderson et al., 2016; Raij et al., 2001; Rubenstein et al., 
1991), as well as an increase in leukocyte adhesion and rolling along venules (“CIGARETTE 
SMOKE ELICITS LEUKOCYTE ADHESION TO,” n.d.). Leukocyte adhesion and rolling is an 
important part of the inflammation response, in response to inflammatory stimuli endothelial 
cells will express chemoattractant molecules on their surface. This allows the leukocytes to 
follow the chemoattractant molecules to the site of cellular injury where they can exit the 
vasculature and act inside the inflamed tissue (Yong, Zheng, & Linthicum, 1997). Leukocyte 
adhesion and rolling is shown to occur in both arterioles (Álvarez et al., 2004) and in venules 
(Kubes et al., 1991; Lehr et al., 1994; Yong et al., 1997). Intravital studies also have shown that 
the increased leukocyte adhesion and rolling is likely due to oxidative mechanisms as treatment 
with superoxide dismutase( Reactive oxygen Species & Hepatocytes, 2004) and vitamin C (Lehr 
et al., 1994) before exposure to cigarette smoke decreases leukocyte adhesion and rolling. 
 While there is currently no published data (that we are aware of) detailing the effects of 
E-cigarettes from an intravital perspective, there is available data concerning the effects of 
nicotine. Most intravital studies focusing on nicotine use an IV administration paradigm, this 
allows the concentration of nicotine in the blood to be precisely controlled. A study by Mayhan 
showed an increase in constriction to norepinephrine in vivo using this paradigm (William G. 
Mayhan, 1999). The results of this study are particularly important, as nicotine is known to have 
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sympathomimetic effects, some mediated through norepinephrine, and the increased levels of 
constriction may play a role in nicotine-induced pathogenesis of cardiovascular disease.  
 The effects of nicotine on basal vascular tone are somewhat controversial. Some studies 
have found that nicotine is vasodilatory (Hilton, 1954) while others have shown no effect on 
vascular tone (Odginai Article, 1992). Black, et al. have shown that nicotine increases the 
vasoconstriction response of the peripheral vasculature this effect may be partially responsible 
for the confusion of the effects of vascular tone in vivo (Black et al., 2001). Despite the effects 
of nicotine on basal vascular tone remaining unclear, nicotine is only a fraction of the 
constituent compounds in E-cigarette vapor and further study to determine the effects of 
commercially available E-cigarette vapor is justified. 
 
1.7 Factors Influencing Peripheral Vascular Tone and Potential Effects of E-cigarettes. 
Peripheral arterioles in the skeletal muscle, and more specifically their diameter, can be used as 
a measure of the amount of blood flow to the muscle. The diameter of a vessel is proportional 
to the force exerted by the smooth muscle and is often referred to as “vessel tone”. Second 
order arterioles (2A’s) are generally used for measuring blood flow to an organ or muscle as 
they are downstream of major resistance arterioles, though they do provide some resistance 
(Bearden, Payne, Chisty, & Segal, 2004). There are several potential effects of E-cigarettes on 
the 2A’s including: acute and chronic effects on the endothelium, stimulation of arachidonic 
acid pathway metabolites, the NO pathway, the actions of endothelin-1, the renin/angiotensin 
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system and sympathomimetic effects of vapor constituents. For the sake of clarity, each of 
these potential effects will be discussed separately in their own subsection. 
1.7.1 Effects on the Endothelium.  Endothelial cells, which line the lumen of the 
vasculature have emerged as important potential therapeutic targets, in large part due to their 
production of NO. NO plays a role in maintaining vessel diameter as well as in anticoagulation, 
leukocyte adhesion and proliferation of vascular smooth muscle cells (Gewaltig & Kojd, 2002). 
NO also plays a role in antioxidant capacity, partly because the NO molecule is itself a free 
radical which allows it to rapidly pair with any unpaired electrons in circulation (Jeremy et al., 
2002). It is possible that an increase in free radicals associated with E-cig usage can sequester 
available NO in the vasculature and effect vessel tone acutely. These acute effects may also be 
compounded by chronic use as E-cig liquid extracts have been shown to be toxic to endothelial 
cells in culture and may cause apoptosis of endothelial cells via an oxidative mechanism 
(Anderson et al., 2016). 
1.7.2 Effects of the Arachidonic Acid Pathway. Metabolites of the arachidonic acid 
pathway, specifically those derived from the cyclo-oxygenase (COX) reactions may also play a 
role in the tone of peripheral arterioles. Arachidonic acid is released by phospholipase A2 
where it can be acted on by the COX enzymes to produce cycloendoperoxides which are then 
acted on by tissue specific enzymes (Weksler, 1981). Platelets are known to produces 
thromboxanes, whereas the endothelium produces prostacyclin and the vascular smooth 
muscle produces prostaglandins (Félétou, Huang, & Vanhoutte, 2011). It is important to note 
that while prostaglandins and prostaclyclins are considered vasodilatory, thromboxanes are 
potent vasoconstrictors that are produced by aggregating platelets (Neppl et al., 2009). Platelet 
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aggregation is known to occur in pulmonary injury models and is also important in the 
production of thrombospondin-1 (TSP-1), which has been shown to attenuate the actions of the 
endothelium after particulate matter inhalation (Mandler, Nurkiewicz, Porter, Kelley, & Olfert, 
2018a) 
The arachidonic acid pathway is also important in immune responses, COX-2 activity is 
associated with inflammatory conditions and has been shown to suppress the activity of several 
immune cells (most notably T cells and NK cells) (Liu, Qu, & Yan, 2015).  The products of COX-2 
may be responsible for alterations of vascular tone acutely and chronically may contribute to 
the dampened actions of the immune system in the lungs and airways of E-cigarette users. 
 1.7.3 Effects of Thrombospondin-1 and its Receptor CD47.  TSP-1 can be produced by 
most cells in the body, but is a major secretory product found in alpha-granules of aggregating 
platelets and secreted during pulmonary injury. Studies have shown that the TSP-1 receptor 
CD47 mediates can mediate its effects on the peripheral vasculature (Mandler, Nurkiewicz, 
Porter, Kelley, & Olfert, 2018b). In the context of E-cigarettes, it is possible that particulate 
matter deposited in the lungs (Manigrasso, Buonanno, Stabile, Morawska, & Avino, 2015) 
stimulates platelet aggregation and therefore TSP-1 secretion following acute exposure to E-
cigarette vapor. In situations in which TSP-1 is chronically elevated it has been shown to 
stimulate vascular smooth muscle proliferation, inhibit endothelial cell proliferation and 
activate MMP enzymes which may also contribute to vascular dysfunction (Lawler, 2002). 
Currently there is no published data concerning acute E-cigarette exposure and the TSP-1/CD47 
axis, however data indicating vascular dysfunction upon E-cigarette exposure (Anderson et al., 
2016; Lehr, 2000) indicates further study into this mechanism is warranted. 
22 
 
1.7.4 Effects of Endothelin-1. Endothelin-1 is another potentially important molecule in 
the E-cig induced vascular dysfunction mechanism. It is known that increased exposure to free 
radicals can upregulate endothelin-1 secretion by vascular endothelial cells, causing long lasting 
vasoconstriction (Houde, Desbiens, & D’Orléans-Juste, 2016). Recent data suggests that a 
feedback between nitric oxide and endothelin-1 may be a major mechanism of myoendothelial 
coupling and therefore arteriolar diameter (Hilgers & De Mey, 2009). Endothelin-1 transcription 
levels are the primary means of regulation of expression, edn-1 transcription (the gene that 
codes for endothelin-1) has been found to be upregulated in hypoxia (Stow, Jacobs, Wingo, & 
Cain, 2011).  This upregulation in expression has been shown to be inhibited by dilazep 
(Shrestha et al., 2004). In the context of E-cigarette use, it is possible that insult to the lungs 
may increase edn-1 transcription and therefore endothelin-1 levels, thereby causing systemic 
vasoconstriction, increased vascular smooth muscle cell proliferation and decreased endothelial 
cell proliferation. This mechanism may also play a role in decreased endothelial-dependent 
dilation with chronic exposure to E-cigarettes (Olfert et al., 2018). 
This mechanism is of interest as expression of endothelin-1 has been shown to increase 
upon inhalation of particulate matter smaller than 2.5 µm in diameter (Brook et al., 2002), and 
chronic elevation of endothelin-1 has been shown to be linked to increased rates of 
cardiovascular events (Brook et al., 2002). Recent data characterizing the particulate matter 
inhaled by E-cigarette users shows that average particulate diameter is between 250-450 nm 
(Ingebrethsen et al., 2012), within range to elicit the response of the endothelin-1 pathway. 
This mechanism is likely important in evaluating the long-term safety of E-cigarette use and 
further research is warranted to characterize the response. 
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1.7.5 Effects of the Renin/Angiotensin System. In physiological conditions the renin-
angiotensin system plays a role in maintaining fluid balance, preventing dehydration and ion 
imbalances. In pathological conditions however, overactivation of the renin-angiotensin system 
has been shown to cause hypertension (Madhur et al., 2010), superoxide production (Jaimes, 
Galceran, & Raij, 1998) and as an activator of NF-κB (Mezzano et al., 2001). These effects are 
caused by the product of the renin angiotensin pathway, angiotensin II. Banday et al. have 
shown that oxidative stress and the renin-angiotensin system can upregulate each other 
causing chronic hypertension and upregulation of inflammatory cytokines (Banday & 
Lokhandwala, 2008).  
 The mechanism underlying how oxidative stress and angiotensin II induced 
hypertension is unclear. Data does, however, show that in situations in which angiotensin II is 
chronically elevated, the kidneys express higher levels of angiotensin II receptor, and therefore 
an exaggerated response to angiotensin II secretion is observed (Banday & Lokhandwala, 2008). 
This response leads to an increase in sodium retention (Beltowski, Wójcicka, Marciniak, & 
Jamroz, 2004) which is likely to further exacerbate the hypertension as well as contribute to 
oxidative stress. 
 Cigarette smoking has been shown to increase expression of angiotensin II as well as 
angiotensin converting enzyme in the lungs (Yuan et al., 2015). The effects of E-cigarettes in this 
context have yet to be evaluated but known increases in oxidative stress upon exposure to E-
cigarette vapor and the likelihood of interplay with the renin-angiotensin system warrants 
further research. 
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1.7.6 Potential Sympathomimetic Effects of Vapor Constituents.  Another potentially 
relevant mechanism of E-cigarettes effecting vascular tone is sympathomimetic effects of 
nicotine or other vapor constituents. While it is known that nicotine is sympathomimetic 
(Chiou, Trzeciakowski, & Klein, 1976), there is no scientific consensus concerning the effects of 
other constituents of E-cigarette liquid on the autonomic nervous system. Human E-cigarette 
exposure studies by Moheimani et al. showed that heart rate variability during an exercise test 
(a measure of sympathetic activation) was only significantly elevated in subjects exposed to E-
cigarette vapor containing nicotine (Moheimani et al., 2017). This means that while vascular 
tone may be altered by E-cigarettes through the other mechanisms listed above, sympathetic 
activation caused by nicotine may exacerbate these effects. Other constituents of E-cigarette 
vapor are not likely to alter tone through this mechanism, but further work is needed in this 
area to better understand what biological effects the individual components of E-cigarette 
vapor have toward health and disease. 
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Tobacco use is widely considered the single greatest risk factor for preventable disease 
and death in the developed world(Center for Disease Control and Prevention, 2011). Effects of 
tobacco smoke and nicotine, the main addictive component of tobacco, have been extensively 
characterized. Electronic cigarettes (E-cigarettes) are among the fastest growing tobacco 
products worldwide, especially among users aged 16-26 (Leventhal et al., 2015). E-cigs work by 
heating a mixture of propylene glycol, glycerin, flavoring and often nicotine with an atomizer 
and allowing the user to inhale the aerosol. It is not surprising that E-cigarettes are increasing 
popularity as marketing attempts to portray E-cigarettes as “safe” alternatives to cigarettes, 
however scientific and clinical evaluations about the acute and chronic effects from using E-
cigarettes are still poorly understood. 
Cigarette smoking has also been known to be linked to pathogenesis of cardiovascular 
disease (CVD) (Smoking & Disease, 2018), this progression is known to occur through 
inflammatory mechanisms. CVD development is in part due to the toxicity of cigarette smoke to 
endothelial cells (Giunzioni et al., 2014; Lehr, 2000). While cell culture and ex vivo studies have 
demonstrated an inflammatory response of neutrophils (Reidel et al., 2010; Higham et al., 
2016) and decreased aortic endothelial dependent relaxation (Olfert et al., 2018) in response to 
E-cig vapor, there is little data detailing the response of the vasculature to E-cigarette exposure 
in vivo. 
The inflammatory response to cigarette smoke has been well characterized; the immune 
system mediates this response through the release of proinflammatory cytokines (“Cigarette 
smoke extract induced cytokine and chemokine,” n.d.). Studies detailing the immune response 
to E-cigs have mostly focused on isolated cells. These studies have found a significant decrease 
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in cellular antioxidant defenses and DNA damage (Ganapathy et al., 2017), increased rates of 
viral infection (Wu et al., 2014) and cell death in vascular endothelial cells (Anderson et al., 
2016). The results of these studies indicate a need for further study on the effects of 
inflammatory cytokine expression in potentially vulnerable tissues. 
Vascular tone is determined by the complex interaction of factors that cause vascular 
smooth muscle to contract or relax (Félétou et al., 2011; Neppl et al., 2009). Several factors can 
regulate vascular tone, including by altering the bioavailability of nitric oxide (Beckman & 
Koppenol, 1996; Jeremy et al., 2002). The immune system is capable of causing oxidative stress 
on the endothelial cells that line the luminal surface of the vasculature and produce nitric oxide 
(Kuzkaya et al., 2003). Other vascular responses to particulate matter may cause acute 
alterations in vessel tone and may be chronically toxic to the cardiovascular system (Brook et 
al., 2002). 
This study aims to address increase knowledge of how acute E-cigarette exposure alters 
peripheral vascular tone, and how chronic exposure may alter the expression of pro-
inflammatory cytokines in potentially vulnerable tissues. 
 
Specific Aim 1: Determine the in vivo effects of acute E-cigarette exposure on vascular 
tone in the gluteus maximus vasculature.  
Our hypothesis is that E-cigarette exposure will decrease vessel diameter through 
decreased nitric oxide production or increased stimulation of vascular smooth muscle 
cells to increase vessel tone. 
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Specific Aim2: Determine the effects of chronic E-cigarettes exposure on cytokine 
expression in various tissues.  
Our hypothesis is that chronic E-cigarette exposure increases the concentration of pro-
inflammatory cytokines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: Methods 
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 C57BL/6 mice were used for all experiments (Jackson Laboratories, Bar Harbor ME.). 
Mice were housed in a temperature and humidity-controlled vivarium with a 12-hour light/dark 
cycle and ad libitum access to standard rodent diet chow and tap water. All experiments were 
approved by and conducted in accordance with the guidelines of the West Virginia University 
Institutional Animal Care and Use Committee. 
3.1 Intravital surgery prep 
 Mice were anesthetized with intraperitoneal injections of Thiobutabarbital (Inactin, 100 
mg/kg) using a 1ml syringe and a 27-gauge needle. Anesthesia was administered via 3 doses 
with approximately 20 minutes between doses. Assessment of adequate anesthesia was 
performed by toe pinch. During anesthesia period a heat lamp was used to prevent 
hypothermia. 
 After anesthesia was determined to be adequate an endotracheal tube (polyethylene 
PE90 tubing approximately an inch long) was inserted via tracheostomy and secured with 
suture (Figure 3.1A). The incision made during tracheostomy was sutured shut to prevent 
insensible fluid loss and to further secure the endotracheal tube in place. Endotracheal tube 
was trimmed to below chin length to mimic anatomical dead space  
 After successful placement of the endotracheal tube an incision just lateral to the dorsal 
midline (Figure 3.1B) was made to visualize the gluteus maximus tendon, the gluteus muscle 
was then exposed by further incisions to the skin around the hindlimb.  After the gluteus 
maximus muscle was exposed it was kept moist with normal saline applied as needed 
throughout the prep. Vannas scissors were used to make an incision into the gluteus tendon  
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Figure 3.1 Legend: A) Tracheostomy in an anesthetized mouse, B) Incision site for 
exteriorization of the gluteus maximus muscle for IVM procedure. Images courtesy of 
W. Kyle Mandler, PhD. 
 
and the gluteus maximus was separated from the gluteus medius by spreading the two apart 
with the blunt edges of the vannas blades. 
Further incisions to the gluteus maximus muscle were used to visualize the vasculature 
within the muscle, after a sufficient portion of the muscle was trimmed away from the tendon a 
suture was tied using a double loop to prevent tying from clamping the muscle (Figure 3.2). 
Traction was applied to the muscle and then the superior and inferior edges of the muscle were 
trimmed away using the traction to facilitate separating the gluteus maximus from the gluteus 
medius (Figure 3.2). Avoiding damage to the neurovascular plexuses on the superior and 
inferior edges of the muscle is imperative as cutting those vessels may result in the death of the 
animal. 
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 Superior and inferior sutures were tied in the same manner as the first tie and the 
muscle was then incubated in a heated bath of physiological saline solution that was sealed 
with stopcock grease. Compressed gas (5% carbon dioxide, balance nitrogen) was bubbled 
through the physiological saline to more closely mimic the interstitial fluid. Heart rate, body 
temperature and bath temperature were monitored throughout, and additional anesthesia was 
given when necessary. 
A water immersion microscope was used to visualize a second-order arteriole in the 
exposed gluteus maximus. A heated stage was used to maintain body temperature, which was 
monitored and automatically regulated using rectal probe. Fluid was replenished in the bath at 
 
Figure 3.2. Approximately 1 cm Externalized portion of the gluteus maximus muscle in 
an anesthetized mouse. Submerged in a 4.5 cm diameter physiological saline solution 
bath. Note the double loop knot in the suture preventing the suture from applying 
pressure to the muscle. Image courtesy of W. Kyle Mandler, PhD. 
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a rate of 4 ml/min to maintain fresh bath environment and temperature. Two separate series of 
were performed, 1) two-hour time course evaluation, and 2) shorter (50-min) time course 
which included vascular reactivity assessments to varying vasodilation (i.e. acytelcholine) 
stimulation. 
3.1.1. Intravital Study 1: The first invtravital experiments were to determine the effects 
of acute E-cigarette exposure on the peripheral vasculature mice for the longest time possible 
(~2hours) while anesthetized under intravital microscopy.  A baseline image of the vessel was 
taken for comparison post exposure. Before exposure, vasodilatory response to 1x10-3 molar 
acetylcholine was also performed by adding the drug to the bath and incubating for 5 minutes. 
Acetylcholine was washed out and vessels returned to baseline before exposure occurred. 
Thereafter, the animal was exposed to vapor for 5 minutes (5 second puffs, 55 ml puff volume, 
30 seconds apart for a total of 10 puffs), or to the smoke of one 3R4F reference cigarette (Univ. 
of Kentucky). Mice were exposed to commercially available French vanilla flavored E-cigarette 
vapor (containing either 0 or 18 mg/ml of nicotine) (VG/PG-0 and VG/PG-18, respectively), 3R4F 
reference cigarette, 100% vegetable glycerin (no nicotine) (VG-0), or 100% propylene glycol (no 
nicotine) (PG-0) using a rodent ventilator and tubing to deliver to the smoke/vapor to the 
endotracheal tube. An untreated (sham) group underwent the same intravital prep but was not 
exposed to any smoke or vapor treatment. 
After exposure, images of the vasculature were taken in 15-minute intervals for up to 
120 minutes (or until the animal died). These images were then measured using ImageJ 
software (NIH), scale was set using measurements from a micrometer and was equal to 300 
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pixels = 100uM. Data was plotted in terms of both absolute vessel diameter and percent change 
from baseline. 
3.1.2. Intravital Study 2. A second series of studies were conducted to obtain better 
time resolution of acute vascular response within 1-hour of exposure and to determine if the 
endothelium-dependent dilation capacity of second-order arterioles was impaired by acute 
exposure to E-cigarette vapor. After baseline was assessed, a 3-point acetylcholine dilation 
curve was obtained (10-7, 10-5 and 10-3 M ACh). Acetylcholine was placed in the bath for 5-
minute intervals with images taken at the end of each interval.  
 After the end of the first acetylcholine curve animals were exposed VG/PG-0, VG/PG-18 
3R4F reference cigarette, or PG-0 using a rodent ventilator and tubing to deliver to the 
smoke/vapor to the endotracheal tube. Images of the vessel were taken in 10-minute intervals 
for 50 minutes  
 After the 50-minute incubation, a second identical acetylcholine dose response curve 
was obtained.  Dilatory capacity was assessed by measuring vessel diameter with ImageJ 
calibrated to measurements from a micrometer. Data was plotted in terms of absolute 
diameter and percent change from baseline. A timeline of the second surgical series is provided 
below for the sake of clarity (Figure 3.3). 
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Figure 3.3 Timeline in minutes showing order of procedures in Study 2. 0 minutes represents 
time at which animal was determined to be adequately anesthetized for the procedure. 
Microscope icon represents the time at which the animal was placed under microscope and 
externalize portion of muscle was placed in the physiological saline bath. 
 
Cytokine Analysis Experiments. 
 Ten-week old female C57BL6/J mice (n=45, purchased from Jackson laboratory, Bar 
Harbor, ME Stock #000664) and randomly assigned to be exposed to either 3R4F reference 
cigarette (University of Kentucky, http://www.ca.eky.edu/refcig), commercially available 
cappuccino flavored E-cigarette vapor (18mg/ml of nicotine 50% propylene glycol:50% 
vegetable glycerin base liquid ratio) or compressed room air (n=15 per group). Mice were 
acclimatized to the new facilities for one week before start of exposures, and group housed by 
treatment (E-cigarette exposed mice were only housed with other E-cigarette exposed mice, 
etc.). Facility conditions were kept constant throughout the exposure period and included a 12-
h light/dark cycle, 22 ± 4°C temperature, and 39 ± 6% relative humidity. Mice were given access 
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to ad libitum tap water and standard rodent chow (18% fat, 24% protein, 58% CHO; Teklad Diet, 
Madison, WI). Cage bedding was changed on a bi-weekly basis and injuries (as a result of 
fighting, etc.) were treated upon consultation of vet staff. 
 Mice exposed to E-cigarette vapor and cigarette smoke were exposed using separate, 
but identical 15.1-liter whole body exposure chambers. Vapor and smoke were generated using 
separate but identical small animal ventilators (HARVARD APPARATUS Dual Phase Control 
Respirator, Model 55-0715, South Natick, Massachusetts). Vapor was generated using a 
custom-built E-cigarette cradle (SONGLE, Dr. Powsiri Klinkhachorn, Dept. of Electrical 
Engineering, West Virginia University, Morgantown, WV) that allowed for precise 5-second 
puffs every 99 seconds (for a total of 38-39 puffs per hour) and a commercially available “tank 
style” E-cigarette device with voltage set at 4.8 V (eGrip™OLED, Joyetch, ShenZhen, China, 
www.joyetch.com). Smoke was generated by inserting and lighting one cigarette every 10 
minutes into the ventilator (6 cigarettes per hour). Animals were acclimatized to the smoking 
protocols by smoking 1 hour per day the first week of exposure, then adding an hour per day 
each week until 4 hours per day was reached.  
 After the acclimatization period, animals were exposed simultaneously in separate 
chambers for 4 hours per day 5 days per week for a total of 8 months. At the end of the 8-
month exposure period animals were given 24 hours of no exposure and fasted for 8 hours. 
Animals were then anesthetized with intraperitoneal ketamine/xylazine. Blood was collected 
from a left ventricular puncture and flash frozen then stored at -80°C for later analysis. Other 
major organs including brain, lung, and gastrocnemius muscle were dissected and flash frozen 
the stored at -80°C. Bronchoalveolar lavage was also performed and fluid was saved, flash 
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frozen and stored at -80°C. Homogenates of brain, lung and gastrocnemius were made using a 
tris-based buffer. A Meso-Scale Discovery (MSD) U-plex kit (Meso-Scale Discovery Rockville, 
Maryland) was run according to manufacturer’s instructions (cytokines tested included: VEGF, 
IL-4, IL-5, IL-6, IL1B, IL-15, IL-10, interferon-gamma, granulocyte-macrophage colony stimulating 
factor and TNF- α). Results are shown below. 
 
Statistical Analyses 
 Repeated measures (rANOVA) was used when more than one measurement of the same 
variable was obtained in the same animal. If a significant main effect for either exposure or 
time was found using rANOVA, Students t-test was used to determine differences by time point 
or between groups. In cases of single measurements, ANOVA was used to determine significant 
main effects between exposure groups, and if a main effect was observed Fisher’s post-hoc 
testing was used to determine significance between groups.  
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Chapter 4: Results 
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Study 1: 2-hour time course  
 Shown in Table 1 are body mass, age of the mice at sacrifice in each respective group 
and sex of animals used in this study. 
 Body Mass Age Sex (% Male) 
Sham 22.0 ± 1.7 g 90 ± 11 days 33% 
E-Cig 22.0 ± 0.8 g 89 ± 3 days 42% 
3R4F 23.5 ± 0.5 g 85 ± 1 days 100% 
Data are presented as mean ± standard error. 
 
Blood vessel diameter was monitored using intravital microscopy for up to 2 hours after 
exposures. Vessel responses are plotted in terms of absolute diameter, and as a percentage of 
pre-exposure diameter (baseline).  Repeated-measures ANOVA show that E-cigarette vapor 
(independent of nicotine content) and 3R4F reference cigarettes shows similar decrease in 
diameter over time (rANOVA P< 0.05 for absolute diameter and rANOVA p< 0.01 for diameter 
with respect to baseline) with both significantly different from sham control groups (Figure 4.1). 
Further investigation using the 2-hour time course paradigm showed that VG/PG-0, 
VG/PG-18PG-0, VG-0 and 3R4F reference cigarette also yield similar changes over time. Data 
were plotted as vessel diameters and with respect to baseline and rANOVA yielded statistically 
significant treatment x time interactions in both cases (P<0.05 for both). These results are 
shown in Figure 4.2 
There were significant differences in male and female animals’ body weights (ANOVA 
P<0.05) and baseline vessel diameter (P<0.05). There was not however, a significant sex by time 
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interaction, or significant differences in clinical data such as heart rate, body temperature or 
bath temperature (P=N.S. for all).  
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Study 1: Two-hour Time Course 
Tobacco cigarette (3R4F) vs. Electronic Cigarette 
Figure 4.1 Time course assessment of 2nd order arteriole vessel diameter in the gluteus 
maximus muscle measured under intravital microscopy before and up to 120-minutes post 
exposure to traditional tobacco cigarettes (3R4F) versus an electronic cigarette. Vessel 
diameters are shown in top panel, and responses normalized to pre-exposure basal diameters 
(set to 1.0) are shown in bottom panel.  Dotted indicates when 5-minute exposure occurred. 
Number of animals in each group is as follows: Sham (n=5), 3R4F (n=2), E-cig (n=19). 
rANOVA Time x Exposure P < 0.05 
rANOVA Time x Exposure P < 0.01 
* 
A 
B 
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Figure 4.2 Time course assessment of 2nd order arteriole vessel diameter in the gluteus 
maximus muscle measured under intravital microscopy before and up to 120-minutes post 
exposure electronic cigarettes using different e-liquid composition and nicotine (i.e., PG-0, 
100% propylene glycol with 0 mg nicotine; VG/PG-0, 50% vegetable glycerin:50% PG with 0 mg 
nicotine; VG/PG-18, 50:50 VG/PG with 18 mg/ml nicotine).  Vessel diameters are shown in top 
panel, and responses normalized to pre-exposure basal diameters (set to 1.0) are shown in 
bottom panel.  Tobacco cigarette (3R4F) shown for reference. Dotted indicates when 5-minute 
exposure occurred. Numbers of animals in each group were as follows Sham (n=5), PG-0 (n=3), 
VG-0 (n=3), VG/PG-0 (n=5), VG/PG-18 (n=8) and 3R4F (n=2). 
  
rANOVA Time x Exposure P < 0.05 
rANOVA Time x Exposure P < 0.05 
A 
B 
* 
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Study 1: Two-hour Time Course 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 shows the response of second order arterioles to inhalation exposures in the gluteus 
maximus muscle of mice.  Pictures on the left are pre-exposure baseline images and pictures on 
the right are the same vessels 30 minutes after exposure. Average diameter (from 3 
measurements) is shown on the image. 
 
 
Sham 
3R4F 
VG/PG-18 
Pre-exposure baseline 30-minutes post exposure 
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Study 2: Vascular Reactivity after 50-Minutes following Vaping  
Shown in Table 2, are body mass, age at time of sacrifice, and sex of animals used in this 
study. 
 Weight Age % male 
Sham 24.3 ± .7 g 84 ± 2 days 100 
3R4F 25.5 ± .6 g 101 ± 5 days 100 
PG-0 22.8± 1.3 g 102 ± 1 days 50 
VG/PG 25.6 ± .3 g 97 ± 3 days 100 
Data presented as mean ± standard error  
 
Vessel diameters were plotted in terms of absolute vessel diameter and as a percentage 
of baseline. rANOVA analysis showed a tendency for time x exposure interaction in absolute 
diameter analysis (P=0.10) and a statistically significant time x exposure interaction with 
respect to baseline (P<0.05). These data are presented graphically in Figure 4.3. 
Vascular reactivity assessment showed no significant impairment in endothelium-
dependent dilation with exposure to 3R4F reference cigarettes (Figure 4.4 A and B). The slopes 
of dilation curves after exposure to 3R4F cigarettes were also not statistically significantly 
different. No significant endothelial impairment was observed with VG/PG-0 orPG-0. However, 
VG/PG-18 was found to have a greater slope after exposure (ANOVA P<0.05; Figure 4.4).  
Analysis of heart rate, by comparing minimum and maximum recorded values, showed 
no statistical difference between groups. Body temperature analysis also showed no statistical 
differences between groups. Bath temperature delta value (maximum minus minimum) analysis 
shows a statistically significant increase in bath temperature variance (ANOVA P<0.05). 
Principally due to greater pre-exposure differences in bath temp in VG/PG groups.  Animals 
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exposed to E-cigarette vapor (VG/VG) experienced an average bath temperature delta value of 
2.6 ± .4 °C, compared to 1.7 ± 0.2 in animals exposed to PG-0, 0.9 ± 0.4 in animals exposed to 
3R4F reference cigarettes and 1.0 ± 0.2 in sham animals (figure 4.5). 
There were significant differences between male and female animals’ vessel diameters 
and body weights (ANOVA P<0.05 for both).  But there were no sex x time interactions in terms 
of vessel response. There were also no significant differences in clinical variables such as heart 
rate, body temperature or bath temperature (P= N.S. for both). 
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Study 2: 50-min Time Course 
Electronic Cigarette using different E-liquids 
 
Figure 4.3 Basal diameters of second-order arterioles in the gluteus maximus muscle before 
and up to 50-minutes post exposure to tobacco cigarettes (3R4F) and E-cigarette using different 
e-liquid composition and nicotine (i.e., PG-0, 100% propylene glycol with 0mg nicotine; VG/PG-
0, 50% vegetable glycerin:50% PG with 0mg nicotine; VG/PG-18, 50:50 VG/PG with 18mg/ml 
nicotine).  Absolute vessel diameters (top) and normalized diameters to pre-exposure (bottom 
panel). Dotted line indicates when 5-minute exposure occurred. Numbers of animals in each 
group were as follows: Sham (n=3), PG-0 (n=6), VG/PG-0 (n=3), VG/PG-18 (n=4) and 3R4F (n=5). 
rANOVA Time x Exposure P=0.10 
rANOVA Time x Exposure P < 0.05 
* 
A 
B 
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Study 2: Vascular Reactivity to Acetylcholine (ACh) 
 
Figure 4.4 Vascular reactivity to increasing acetylcholine (ACh) concentration of Pre and 1-hour 
Post exposure to traditional tobacco cigarette (3R4F, shown in A and B) and electronic 
cigarettes (shown in C and D) with differing e-liquid composition and nicotine (i.e., PG-0, 100% 
propylene glycol with 0 mg nicotine; VG/PG-0, 50% vegetable glycerin:50% PG with 0 mg 
nicotine; VG/PG-18, 50:50 VG/PG with 18 mg/ml nicotine).  A & C show vessel diameters 
obtained from 2nd order arterioles in the gluteus maximus muscle under intravital microscopy.  
B & D show responses normalized to baseline diameters (set to 1.0). Numbers of animals in 
each group were as follows: Sham (n=3), PG-0 (n=6), VG/PG-0 (n=3), VG/PG-18 (n=4) and 3R4F 
(n=5).    
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Figure 4.5 Heart rate (top), body temperature (middle) and intravital bath temperature 
(bottom) measurements obtained during Study 2 data collection.  PG-0, 100% propylene glycol 
with 0 mg nicotine; VG/PG-0, 50% vegetable glycerin:50% PG with 0 mg nicotine; VG/PG-18, 
50:50 VG/PG with 18 mg/ml nicotine; C, degrees Celsius. Numbers of animals in each group 
were as follows: Sham (n=3), PG-0 (n=6), VG/PG-0 (n=3), VG/PG-18 (n=4) and 3R4F (n=5).    
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Study 3: Chronic Exposure and cytokine analysis 
  After cytokine assays were run, ANOVA was used to determine if statistical significance 
existed between groups. The P-values of each ANOVA are shown in Table 4.1. Statistically 
significant changes and tendencies were plotted in Figure 4.6. IL-6 content in the serum of 
groups was found to be statistically significant (P<0.05) with air exposed animals expressing 
3.535 ± 0.917 pg/ml, 3R4F exposed animals expressing 0.926 ± 0.273 pg/ml and E-cigarette 
exposed animals expressing 1.503 ± 0.658 pg/ml. Analysis of VEGF and GM-CSF contained data 
from 6 animals per group IL-6 analysis in the serum contained data from 8 air exposed animals, 
7 3R4F exposed animals and 9 E-cigarette exposed animals. 
While not statistically significant, VEGF content tended to be different in the lungs 
(ANOVA P= 0.059) with air exposed animals expressing 8.266 ± 0.866 pg/ml, 3R4F exposed 
animals expressing 7.966 ±1.366 pg/ml and E-cigarette exposed animals expressing 4.455 ± 
1.156 pg/ml. Bronchoalveolar lavage fluid (BALF) also tended to be different among groups 
(ANOVA P= 0.06) with air exposed animals expressing 0.418 ±0.066 pg/ml, 3R4F exposed 
animals expressing 0.563 ± 0.062 pg/ml, and E-cigarette exposed animals expressing  0.07 ± 0.0 
pg/ml. GM-CSF expression in the lungs tended to be different between groups with air exposed 
animals expressing 0.07 ±0.01 pg/ml, 3R4F exposed animals expressing 0.13 ± 0.04 pg/ml and E-
cigarette exposed animals expressing  0.04 ± 0.01 pg/ml. These results are presented 
graphically in Figure 4.6. 
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Study 3: Chronic exposure to E-Cigarette Vapor 
 
ANOVA Exposure Effect P-values for All Cytokines 
 
Lung Gastrocnemius Serum BALF 
VEGF 0.059 0.470 0.934 0.060 
TNF-a 0.281 0.666 0.450 0.986 
GM-CSF 0.056 0.648 0.446 0.096 
IFN-gamma 0.662 0.383 0.625 ISD 
IL-1B 0.901 0.405 0.347 0.226 
IL-4 0.910 0.181 ISD ISD 
IL-5 0.519 0.484 0.930 0.331 
IL-6 0.543 ISD 0.040 ISD 
IL-10 0.150 0.101 0.253 0.192 
IL-15 0.210 0.698 0.714 ISD 
 
Table 3 shows P-values of ANOVA analysis of cytokine expression in tissues of Mice 
chronically exposed to either 3R4F reference cigarette, commercially available Cappuccino-
flavored E-liquid (Joyetech, ShenZhen, China) (18 mg/ml nicotine) or filtered room air. Bold 
values showed either tendencies (P<0.06) or statistically significant (P<0.05) changes in 
cytokine levels. Cells labelled ISD had insufficient data for ANOVA analysis. Cytokines tested 
were: vascular endothelial growth factor (VEGF), tumor necrosis factor- alpha (TNF-a), 
granulocyte-macrophage colony stimulating factor (GM-CSF), interferon-gamma (IFN-
gamma) and interleukins (IL) 1B, 4, 5, 6, 10, and 15. 
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Figure 4.6 shows expression of cytokines in tissues highlighted in table 4.1 as either a 
tendency to be different (VEGF in BALF and lung, as well as GM-CSF in lung) or statistically 
different (IL-6 in serum). Data are presented as mean ± standard error. VEGF and GM-CSF 
analysis contained 6 animals per group. Number of animals in IL-6 numbers were as follows, 
Air (n=8), 3R4F (n=7), E-cig (n=9). 
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Chapter 5: Discussion, Limitations and Future Directions 
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Discussion 
 The principal finding of this study is that acute E-cigarette exposure causes peripheral 
blood vessel constriction, independent of nicotine, in the gluteus maximus muscle of mice. 
These effects are also observed with exposure to either 100% propylene glycol or vegetable 
glycerin, suggesting the base constituents of the E-liquid solution may be a key factor initiating 
vasoconstriction. Despite causing vasoconstriction, the ability of the endothelium to dilate to a 
vasodilatory stimulus (i.e. acetylcholine) remains largely unimpaired 1 hour after a single acute 
E-cigarette exposure. When a chronic E-cigarette paradigm is applied (i.e. 8 months of daily 
exposure) the expression of growth factors and cytokines are also altered in several tissues, 
suggesting altered immune and metabolic function. Taken together, these data show that 
alteration in vascular function are similar between E-cigarettes and traditional cigarettes which 
calls into question the safety of E-cigarettes and suggests that the long-term effect on blood 
vessels with E-cigarette use will likely be similar to those of regular cigarettes. 
 
Acute Time Course Responses 
We evaluated the time course response in two separate studies. Our first study 
observed the longest timeframe we could, using our intravital microscopy prep (approximately 
2 hours). The second study was designed to provide a greater temporal resolution in the 
observed vasoconstriction response and determine if endothelial function was impaired. These 
series of experiments provide early evidence establishing the concept that acute E-cigarette 
exposure alters peripheral vascular tone. Figure 4.2 shows that E-cigarette exposure 
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(independent of nicotine content) causes marked peripheral vasoconstriction, to a degree that 
mimics a 3R4F reference cigarette. The observed vasoconstriction lasts longer than 120 minutes 
post exposure in all cases. Further study will be needed to determine the total amount of time 
that vasoconstriction persists, this study is constrained by the survival time under anesthesia of 
mice in the prep. 
We observed no significant differences in vessel tone when exposing animals to vapor 
with or without nicotine, suggesting that other mechanisms are responsible for altered tone 
after exposure. Mice were exposed to (nicotine-free) 100% concentrations of either base 
component in E-liquid (i.e. PG-0 or VG-0) each produced vasoconstriction that mimics 3R4F 
cigarettes (Figure 4.2). Because PG-0 and VG-0 produced similar patterns of vasoconstriction, 
vaporizing the two components of the base liquid either, 1) produces similar breakdown 
products (i.e. carbonyl compounds), or 2) produces similar doses of particulate matter that 
could drive vasoconstriction. Other studies have reported increases in oxidative stress upon 
exposure to E-cigarette aerosols and extracts, suggesting that the mechanism of 
vasoconstriction we are observing in vivo may be a consequence of increased circulating 
reactive oxygen species (ROS) associated with oxidative stress (Anderson et al., 2016; Reidel et 
al., 2017; Ganapathy et al., 2017). ROS is known to be present in the vapor of E-cigarettes, as 
well as the smoke of traditional cigarettes (Sussan et al., 2015), and known to alter endothelial 
cell function in acute and chronic exposure paradigms (Cimmino et al., 2015; M. Kim et al., 
2014). 
 Inhalation of particulate matter may also be an important factor since it has been shown 
to increase expression of endothelin-1 (Brook et al., 2002; Houde et al., 2016). If particulate 
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matter is driving vasoconstriction, it is possible that endothelin-1 is involved. Aldehyde 
exposure, which is found in E-cigarette vapor, has been linked to cardiopulmonary toxicity 
which may involve the actions of TRPA-1 are thought to play a role (Conklin, 2016). One or both 
pathways may play a role in the effects of E-cigarettes on the peripheral vasculature. 
 Another potential mechanism of the vasoconstriction we observe is the TSP-1/CD47 
pathway and its action on NO bioavailability. TSP-1 has been shown to be highly expressed in 
pulmonary injury (Mandler et al., 2018a). Preliminary data from our lab indicates that CD47 
knockout mice (that don’t express the TSP-1 receptor CD47) may, in part, be protected from 
vasoconstriction after exposure to E-cigarette vapor (data not shown). This could indicate that 
E-cigarettes might increase expression of TSP-1, which in turn could decrease bioavailable NO, 
resulting in increased basal vessel tone (or constriction).  TSP-1 expression has also been shown 
to increase endothelial cell apoptosis (Nör, Mitra, & Sutorik, 2000), chronic periodic elevation of 
TSP-1 may also contribute to increased arterial stiffness (through decreased NO bioavailability) 
and decreased endothelial response (by increasing endothelial apoptosis)(Nör et al., 2000).  
Arguing against a NO-mediated mechanism, however, is the observation that endothelial cell 
responses to ACh (i.e. vessel reactivity, discussed below) are largely unaffected the time point 
we studied (i.e. ~1-hour post exposure). 
 Neural input may also play a role in our findings, the sympathetic nervous system alters 
vascular tone through the effects of norepinephrine (Malpas et al., 2001). Nicotine has also 
been shown to decrease the clearance of norepinephrine (Brees et al., 2008). There is also 
evidence that particulate matter inhalation (from diesel fuel exhaust) causes activation of the 
sympathetic nervous system, the mechanisms here, however, are unclear (Carll et al., 2013). If 
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particulate matter drives sympathetic activation, vasoconstriction with exposure to E-cigarettes 
should be expected. It would also be expected however that heart rate would increase due to 
sympathetic stimulation, which our data does not show. 
 
Vascular Reactivity  
The ability of a blood vessel to dilate to acetylcholine is a measure of the ability 
endothelium to produce NO. Impaired NO synthesis has been shown to be an early predictor in 
the development of CVD (Beckman & Koppenol, 1996; Jeremy et al., 2002). In vivo data in 
humans has shown that a single exposure to cigarette smoke impairs endothelium-dependent 
dilation (Lekakis et al., 1997).  To assess endothelial dilatory capacity, we compared a pre-
exposure acetylcholine dilation response, to identical doses of acetylcholine 50 minutes after 
exposure. Figure 4.4 shows that endothelial function was not different between pre- and post-
exposure dilation curves in either E-cigarettes or traditional cigarettes, except for the VG/PG-18 
group. These data, while not in disagreement with previous findings published from our lab that 
chronic E-cigarette exposure causes impairment of endothelium-dependent dilation, does 
suggest that a single exposure is not enough to cause impaired endothelial cell response to a 
vasodilatory stimulus. Data illustrating the endothelial response of humans in response to E-
cigarette exposure found significant impairment in ability to dilate 5-minutes post-exposure, 
indicating that endothelium impairment caused by a single E-cigarette exposure may be 
resolved sooner than 50 minutes (Carnevale et al., 2016), in which case, we would have missed 
detecting any impairment at our >50-minute time point.  We did, however, observe that 
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VG/PG-18 exposure group resulted in greater slope of the acetylcholine curve post exposure. 
This may be indicative of a role of nicotine, or some other vapor constituent in sensitizing the 
endothelium to acetylcholine. Nicotine may be the most logical factor because none of the 
other vapor exposed groups elicited this response, however the slope of 3R4F animals was not 
different. This suggests there may be some other factor (other than nicotine) involved. It is also 
possible that greater slope post exposure may be an artifact of dilating from a constricted point 
to the same diameter. This would mean endothelial function is not impaired, which is 
consistent with nicotine having a short half-life (9-10 mins) and therefore not effecting the 
endothelium 50-minutes post exposure (Siu & Tyndale, 2007). There was also no verification of 
nicotine content in the serum of our mice, it is possible that levels of nicotine from 3R4F versus 
E-cigarette (with VG/PG-18) were different. 
We monitored clinical variables (i.e. heart rate and body temperature) to evaluate the 
physiological stability of animals throughout the procedure. In general heart rate and body 
temperature were stable through all groups throughout the procedure, however VG/PG-18 
shows a potential activation of the sympathetic nervous system with a sharp post exposure 
increase in heart rate. The sympathetic activation is tempting to attribute to nicotine, however 
(as mentioned before) since we do not yet know if serum levels of nicotine were the same 
between the groups, we cannot know if this was a nicotine mediated effect. 
We also monitored bath temperature surrounding the externalized muscle, this 
temperature most closely measures the temperature of the micro-vessel environment. 
Variability in bath temperature in the pre-exposure portion of the experiment was likely due to 
the need of the apparatus used for heating the bath to warm up. While it is possible the lower 
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pre-exposure bath temperatures could have influenced the reactivity responses, we would note 
that even the groups which has a constant temperature (i.e. sham and PG-0, Figure 4.5) 
exhibited no change in slope pre vs. post exposure.  This suggests the absolute difference in 
temperature we observed in the VG/PG-18 and VG/PG-0 groups (delta temperature ranging 
from 0.8 - 1.6 °C) did not likely alter the outcome (i.e. no change in slope for VG/PG-0, and a 
steeper slope for VG/PG-18 post exposure). Supporting this notion, a previous study suggests 
that temperature differences this small should not greatly influence vessel responses, as 
endothelial dysfunction was found to not be impaired even after hypothermic circulatory arrest 
with a delta temperature change of 19°C (i.e. from 37 °C to 18 °C) (Cooper et al., 2000). It 
should also be noted, the lower absolute temperature of the bath (~35 °C) compared to body 
core temperature (37 °C) is also consistent with data frequently obtained during IVM 
procedures in peripheral skeletal muscle. 
Lastly, our study also found no significant effect of sex on the vascular response to E-
cigarette vapor. This is an interesting finding considering the known vaso-protective effects of 
estrogen (Collins, 1985). The protective effect of estrogen has, however been shown to 
decrease in response to increasing levels of oxidative stress such as exposure to E-cigarette 
vapor (Wassmann et al., 2001). This raises concerns about the vaso-protective effects of 
estrogen being diminished with chronic E-cigarette use. 
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Cytokine Analysis 
In prior work, we exposed mice to E-cigarette vapor for 8 months and report a 
significant decrease in vascular reactivity to acetylcholine (Olfert et al., 2018). As part of this 
project we sought to evaluate the response of pro-inflammatory cytokines and growth factors 
in tissues obtained from these mice. The lungs, BALF, serum and gastrocnemius muscle were 
chosen as key sites likely to be affected by vaping. 
The only significant finding we observed was a decrease in serum levels of IL-6 in E-
cigarette and 3R4F cigarette exposed mice. The levels of IL-6 in E-cigarette exposed mice 
behaved more like cigarette animals than air exposed controls. IL-6 has been shown to 
contribute to immunity by stimulating immune cell response to pathogens (van der Poll et al., 
1997). Decreases in serum IL-6 may be indicative of lower levels of immune system activity and 
contribute to the increased latency and rates of infections described above. IL-6 levels have 
been previously linked to the development of cardiovascular disease, as well as insulin 
resistance (De Mello et al., 2009). The observed changes in IL-6 with our study are consistent 
with these findings, the lack of changes observed with TNF-α is interesting in this context as IL-6 
and TNF-α expression changes are generally thought to be concomitant (Azzolina, Bongiovanni, 
& Lampiasi, 2003; De Mello et al., 2009). Other studies have shown increases in TNF-α in 
response to cigarette smoke and E-cigarette exposure ( Reidel. et al., 2017; Reidel et al., 2010).  
 VEGF levels tended to be lower in both lungs and BAL fluid, the role of VEGF in 
angiogenesis has been extensively characterized (Carvalho, Blank, & Shoenfeld, 2007; Mayer et 
al., 2005). VEGF has been shown to play a role in vascular permeability, which may precede 
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pulmonary inflammation in asthma patients (Khor et al., 2009).  VEGF has also been shown to 
exert anti-apoptotic effects (Štefanec, 2000). Decreases in lung VEGF may indicate an increase 
in endothelial apoptosis. VEGF has also been linked to altering vascular permeability, a concern 
in the development of asthma (Khor et al., 2009). Asthma has been raised as a possible concern 
with chronic E-cigarette use by other groups (Higham et al., 2016), these results support that 
notion.  further research will be needed to determine if the tendency observed in this study is 
physiologically significant.  
 GM-CSF in the lungs also tended to be different among groups, E-cigarette exposed 
animals showed lower concentrations of GM-CSF than cigarette exposed animals. High levels of 
GM-CSF have been attributed to the development of COPD phenotype in the past (Botelho et 
al., 2011). This may hint at COPD developing by different mechanisms with cigarette and E-
cigarette use, but more research will be needed to determine if that is the case. The effects of 
GM-CSF on the peripheral vasculature are unclear and further research will be needed to 
determine the implications of this observation. 
 
Limitations 
 A major concern surrounding all E-cigarette research is the highly variable way to use E-
cigarettes, from the composition of liquids, temperature, voltage and puff topography. The 
exposure paradigm used in the acute studies (10 puffs, 5 second puff duration, 30 seconds 
apart) was meant to mimic the nicotine content of a single cigarette (Farsalinos, Spyrou, et al., 
2015). In the chronic study we attempted to match for time and total particulate matter (TPM) 
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exposure. Changing exposures may alter outcomes that we observe, but it should be noted that 
our exposure is light compared to that typically used in smoking-related studies. This means 
that, even at low levels of exposure, chronic E-cigarette use is likely to have significant effects 
toward cardiovascular health, suggesting that there may no real safe level of exposure. 
 Current generations of E-cigarettes allow for custom settings of power applied (i.e. 
watts, voltage) and temperature. In our study, we controlled the watts of the E-cigarette 
device, but the results are likely to vary if one uses different wattage or voltage (especially in 
chronic exposures). The flavor of the E-cigarette liquids is another variable that could have 
great influence on the presence of chemical breakdown products in the vapor created, not to 
mention that the settings of E-cigarette device may also alter the breakdown products of in the 
flavorings, resulting in a complex and potentially highly variable vapor composition. While it is 
not practical to test every combination, our data used both flavorings (i.e. VG/PG-18 and 
VG/PG-0) vs. no flavorings (i.e. PG-0 and VG-0) will little difference between the observed 
results.  Thus, at least from a vascular response perspective (i.e. base tone and reactivity to 
stimulus), it would appear that French Vanilla flavoring had no additional effects.  This does not, 
however, preclude the possibility that other combinations of either flavors or device settings 
might behave differently and produce worse outcomes. 
 To make in vivo measurements, we had to use a surgical prep under anesthesia. The use 
of anesthesia may have had some influence on the vasculature, but all groups were treated the 
same and animals served as their own control, therefore the responses we observed are 
expected to be qualitatively accurate, even if the heart rate (and other clinical variables) are 
quantitatively influenced by anesthesia.  Prior studies also support the use of Inactin for IVM 
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procedures due to the minimal cardiovascular side effects.  The need for mice to be exposed 
through the endotracheal tube may have eliminated ancillary parasympathetic input that could 
come from flavoring activation on sweet tastes. Parasympathetic input in this context may 
counteract the effects of nicotine as a sympathomimetic. While the effects on peripheral 
vasculature are not likely to be significantly altered by parasympathetic input, the arteries that 
perfuse the digestive tract may be altered. 
 The biggest limitation, at this point, is the lack of confirmation that nicotine levels were 
the same in nicotine treated groups. While we have obtained serum post exposure these 
analyses have not yet been carried out. It is possible, that PG/VG-18 or 3R4F exposed animals 
received different levels of nicotine and increasing the relative dose of nicotine may increase 
the effects (i.e. increases in heart rate).  
 
Future work 
 The primary focus of E-cigarette research moving forward should focus on how different 
alterations of settings and vapor composition on commercially available devices effect human 
health. Our studies highlight the implications of E-cigarette vapor on the vasculature with 
implications toward the immune system, but other body systems may be affected also.  Our 
data suggest further research regarding the mechanism of peripheral vasoconstriction is 
warranted. There is, indeed, a complex interplay of multiple control systems that ultimately 
control vascular and immune cell function and understanding these pathways will allow insight 
into treatment options to potentially combat chronic disease.  
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Oxidative damage to the endothelium has been a major player in the previous findings 
of our lab, and endothelial protection might be accomplished by simultaneous E-cigarette 
exposure and antioxidant administration.  It would useful to evaluate the NO pathway by 
including administration of a nitric oxide synthase inhibitor (i.e. L-NAME) to the microvascular 
bed. If vasoconstriction is observed while eNOS is inhibited, then the bioavailability of NO in the 
observed vasoconstriction will be called into question. In the event inhibiting eNOS does not 
alter changes to vascular tone, administration of antioxidants may provide insight into 
mechanism, superoxide for example, may be produced by the breakdown of E-liquid and its 
effects on the endothelium may be prevented by administering superoxide dismutase 
(Förstermann & Münzel, 2006; Raij et al., 2001). It would also be worthwhile to compare free 
radical content (using electron paramagnetic resonance studies) of the E-cigarette vapor and 
3R4F reference cigarettes. Understanding the relative exposure to free radicals can give insight 
into the oxidative load (and presumably endothelial damage) the animals are exposed to. 
 If the NO pathway is shown to be unaffected, testing the effects of vasoconstrictor 
elements would be a logical next step.  Endothelin-1 would be particularly interesting since it is 
known to increase in the lung following inhaled exposure to particulate matter. ELISA assays or 
western blot techniques could be used to detect circulating levels of endothelin-1 in the serum. 
Because endothelin-1 expression is primarily regulated through gene expression real-time PCR 
techniques may be used to determine relative levels of gene expression if protein levels of 
endothelin-1 are not elevated (Houde et al., 2016; Marasciulo, Montagnani, & Potenza, 2006; 
Shrestha et al., 2004). The vasodilatory drug Dilazep works by inhibiting endothelin-1 synthesis, 
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administration of dilazep prior to E-cigarette exposure using an intravital approach may provide 
insight into the mechanism of vasoconstriction we observe (Shrestha et al., 2004).  
 More testing of the effects of E-cigarettes on the immune system are needed. Future 
work should also focus on the role of neutrophil infiltration in the lungs observed by other 
studies.  Chronic exposure to E-cigarettes may cause clinically significant impairment in the 
lungs if the realistic levels of E-cigarette exposure drives the neutrophil inflammatory response. 
This would lead to concerns of the development of COPD with chronic E-cigarette use.  
 Newer E-cigarette products, that present unique ingredients and therefore vapor 
composition, are also beginning to appear on the market. These include vitamin vapes, 
cannabidiol vapor products and Juul. The claims of safety surrounding these products mimic 
those that surrounded E-cigarettes when they first appeared on the market, these claims are 
largely not scientifically validated. Many of these products use the same “base” solution as E-
cigarettes. Because the effects of E-cigarettes on the vasculature are independent of nicotine 
and seem to be caused by the base solution itself, the outcomes of chronic use of these 
products is therefore likely to be similar even though the device system may vary. More studies 
are needed in the safety of inhaling the active ingredients of these products, and to the 
determine the effects of device settings (i.e. temperature, power, etc.) on producing the 
compounds inducing the changes in vascular function. 
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